RE:RE:RE:RE:Deal before end of year? Dimension (DMTX) was also in my watch list (pity that I missed that one too while I am here) but I would say it is an exception as it is a gene theraphy company and there is a competing bid going on (previous offer from Regenxbio was 3.41 pps and today they announced 5.50 pps offer from Ultragenyx). Actually this in theory should also happen for Sirona if there are really more than one parties interested but unfortunately we do not know what is going on. Imagine the market reaction of a news release stating "Sirona received two respective terms sheets and currently in the final phase of discussions with potential partners." Such statement would not harm any negotiation I guess. Each partner probably knows what is the offer of the other side.
BTW Sirona already shared poster on Keloid previously and I also agree that it is promising. I commented in detail on it previously.
https://pbs.twimg.com/media/C-w0rShXYAEyjSd.jpg:large
I would be surprised if they did additional work on keloid. Probably they will say that there is a significant interest from big companies and they are evaluating the potential of the asset etc which is something very familiar.
If they do not share any solid progress on the update I do not think it will push the share price higher. We need to see some results rather than expect, hope, anticipate type of comments. They did not show to us and if they have had it would be a less stressfull wait for everybody. They would have less pressure from investor side and we would have felt more confident.
Let's see what the following days will bring.
GL